Search company, investor...

Predict your next investment

Non-Profit Foundation
peierls-foundation.idilogic.aidpage.com

Investments

7

Portfolio Exits

3

About Peierls Foundation

The Peierls Foundation is dedicated to supporting higher education, international relief and programs benefiting children/youth, services and civil rights. It also contributes to national organizations that focus on health, medical research, immigrants, reproductive health and family planning.

Headquarters Location

114 W 47th Street

New York, New York, 10036-1510,

United States

Want to inform investors similar to Peierls Foundation about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Peierls Foundation News

ArcherDX Closes Up To $60M Series B Financing

May 15, 2019

ArcherDX, Inc. , a Boulder, Colo.-based molecular technology company dedicated to developing solutions that advance the application of personalized genomic medicine, closed an up to $60m Series B financing round. The round was led by Perceptive Advisors, with participation from existing investors PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation. The company intends to use the funds to scale operations, advance its companion diagnostic program that spans solid tumors, hematological malignancies and circulating tumor DNA (ctDNA) applications, and expand its minimal residual disease monitoring program accelerating access to a greater than $20 billion worldwide market opportunity. Led by Jason Myers, co-founder and chief executive officer, ArcherDX has developed a liquid biopsy-based minimal residual disease monitoring solution that combines Anchored Multiplex PCR (AMPTM) chemistry with a proprietary algorithm to construct optimal patient-specific assays that are intended to be used to monitor disease and detect progression or recurrence earlier than current standard of care testing. The company plans to develop the assay as a decentralized or kitted in vitro diagnostic solution for global regulatory clearance, with the intention of improving test result turn-around time and lowering per patient testing costs. To date, ArcherDX has raised up to $95m in financing. FinSMEs

Peierls Foundation Investments

7 Investments

Peierls Foundation has made 7 investments. Their latest investment was in ArcherDx as part of their Series B on May 5, 2019.

CBI Logo

Peierls Foundation Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/15/2019

Series B

ArcherDx

$60M

No

5

3/20/2018

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/15/2011

Series B

Subscribe to see more

$99M

Subscribe to see more

0

8/8/2008

PIPE - II

Subscribe to see more

$99M

Subscribe to see more

0

6/8/2007

PIPE - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/15/2019

3/20/2018

3/15/2011

8/8/2008

6/8/2007

Round

Series B

Series A

Series B

PIPE - II

PIPE - II

Company

ArcherDx

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$60M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

10

0

0

0

Peierls Foundation Portfolio Exits

3 Portfolio Exits

Peierls Foundation has 3 portfolio exits. Their latest portfolio exit was ArcherDx on June 22, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/22/2020

Acquired - II

$99M

13

12/19/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/13/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/22/2020

12/19/2017

9/13/2016

Exit

Acquired - II

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

13

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.